Olanzapine Oral Soluble Film(Jiangsu Hansoh)

奥氮平口溶膜（江苏豪森）

Report date: 2025/07/11 10:55:15

Base Information

Drug NameOlanzapine Oral Soluble Film(Jiangsu Hansoh)
Drug Alias Nameolanzapine奥兰扎平olanzapinum奥兰氮平olanzapina +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D2 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists
TargetsDopamine D1 receptorDopamine D2 receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsSchizophreniaBipolar Disorder
Approved Indications in ChinaSchizophreniaBipolar Disorder
Original Approved Country/TerritoryMainland China
Original Approved Date2020/11/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG